Skip to main content

Advertisement

SpringerLink
Log in

Photoprotective effects of nicotinamide

  • Perspective
  • Published:
Photochemical & Photobiological Sciences Aims and scope Submit manuscript

Abstract

Sun protective measures can reduce numbers of both precancerous actinic keratoses and cutaneous squamous cell carcinomas within relatively short periods of time even in high-risk populations. Sunscreens, which tend to provide greater protection against shortwave UVB than against longer wavelength UVA radiation, can however provide only partial protection from the mutagenic and immune suppressive effects of sunlight. In large part, this reflects poor compliance with proper sunscreen application and reapplication. Skin cancer is by far the most common malignancy in Caucasian populations, and additional strategies to reduce the morbidity and economic burden of this disease are now urgently needed. Nicotinamide, the amide form of vitamin B3, is an inexpensive agent which is used for a variety of dermatological applications with little or no toxicity even at high doses. Nicotinamide has photoprotective effects against carcinogenesis and immune suppression in mice, and is photoimmunoprotective in humans when used as a lotion or orally. UV irradiation depletes keratinocytes of cellular energy and nicotinamide, which is a precursor of nicotinamide adenine dinucleotide, may act at least in part by providing energy repletion to irradiated cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AK:

Actinic keratosis

BCC:

Basal cell carcinoma

CHS:

Contact hypersensitivity

DTH:

Delayed type hypersensitivity

MED:

Minimal erythema dose

NAD:

Nicotinamide adenine dinucleotide

PARP:

Poly-ADP-ribose polymerase

PPD:

Purified protein derivative

SCC:

Squamous cell carcinoma

SDH:

Succinate dehydrogenase

SPF:

Sun protection factor

ssUV:

Solar-simulated ultraviolet

References

  1. M. P. Staples, M. Elwood, R. C. Burton, J. L. Williams, R. Marks and G. G. Giles, Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985, Med. J. Aust., 2006, 184, 6–10.

    Article  PubMed  Google Scholar 

  2. V. D. Criscione, M. A. Weinstock, M. F. Naylor, C. Luque, M. J. Eide and S. F. Bingham, Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs topical tretinoin chemoprevention trial group, Cancer, 2009, 115, 2523–2530.

    Article  PubMed  Google Scholar 

  3. R. Marks, Epidemiology of non-melanoma skin cancer and solar keratoses in Australia: a tale of self-immolation in Elysian fields, Australas. J. Dermatol., 1997, 38 (suppl) S26–S29.

    Article  PubMed  Google Scholar 

  4. U. Leiter and C. Garbe, Epidemiology of melanoma and nonmelanoma skin cancer - the role of sunlight, Adv. Exp. Med. Biol., 2008, 624, 89–103.

    Article  PubMed  Google Scholar 

  5. L. K. Dennis, M. J. VanBeek, L. E. Beane Freeman, B. J. Smith, D. V. Dawson and J. A. Coughlin, Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis, Ann. Epidemiol., 2008, 18, 614–627.

    Article  PubMed  PubMed Central  Google Scholar 

  6. J. C. Van Der Pols, G. M. Williams, N. Pandeya, V. Logan and A. C. Green, Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use, Cancer Epidemiol., Biomarkers Prev., 2006, 15, 2546–2548.

    Article  Google Scholar 

  7. S. C. Thompson, D. Jolley and R. Marks, Reduction of solar keratoses by regular sunscreen use, N. Engl. J. Med., 1993, 329, 1147–1151.

    Article  CAS  PubMed  Google Scholar 

  8. S. Darlington, G. Williams, R. Neale, C. Frost and A. Green, A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses, Arch. Dermatol., 2003, 139, 451–455.

    Article  PubMed  Google Scholar 

  9. L. K. Dennis, L. E. Beane Freeman and M. J. VanBeek, Sunscreen use and the risk of melanoma: a quantitative review, Ann. Internal Med., 2003, 139, 966–978.

    Article  Google Scholar 

  10. A. Freiman, G. Bird, A. I. Metelitsa, B. Barankin and G. J. Lauzon, Cutaneous effects of smoking, J. Cutaneous Med. Surg., 2004, 8, 415–423.

    Article  Google Scholar 

  11. E. Nagore, L. Hueso, R. Botella-Estrada, A. Alfaro-Rubio, I. Serna, J. Guallar, I. Gonzalez, I. Ribes and C. Guillen, Smoking, sun exposure, number of nevi and previous neoplasias are risk factors for melanoma in older patients (60 years and over), J. Eur. Acad. Dermatol. Venereol., 2010, 24, 50–57.

    Article  CAS  PubMed  Google Scholar 

  12. T. I. Ibiebele, J. C. Van Der Pols, M. C. Hughes, G. C. Marks, G. M. Williams and A. C. Green, Dietary pattern in association with squamous cell carcinoma of the skin: a prospective study, Am. J. Clin. Nutr., 2007, 85, 1401–1408.

    Article  CAS  PubMed  Google Scholar 

  13. H. S. Black, J. I. Thornby, J. E. J. Wolf, L. H. Goldberg, J. A. Herd, T. Rosen, S. E. Bruce, J. A. Tschen, L. W. Scott and S. Jaax, Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer, Int. J. Cancer, 1995, 62, 165–169.

    Article  CAS  PubMed  Google Scholar 

  14. A. T. Dinkova-Kostova, J. W. Fahey, S. N. Jenkins, S. L. Wehage and P. Talahay, Rapid body weight gain increases the risk of UV radiation-induced skin carcinogenesis in SKH-1 hairless mice, Nutr. Res., 2008, 28, 539–543.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. L. K. Dennis, J. B. Lowe, C. F. Lynch and M. C. Alavanja, Cutaneous melanoma and obesity in the Agricultural Health Study, Ann. Epidemiol., 2008, 18, 214–221.

    Article  PubMed  PubMed Central  Google Scholar 

  16. S. E. Ullrich, Mechanisms underlying UV-induced immunosuppression, Mutat. Res., Fundam. Mol. Mech. Mutagen., 2005, 571, 185–205.

    Article  CAS  Google Scholar 

  17. F. J. Moloney, H. Comber, P. O’Lorcain, P. O’Kelly, P. J. Conlon and G. M. Murphy, A population-based study of skin cancer incidence and prevalence in renal transplant recipients, Br. J. Dermatol., 2006, 154, 498–504.

    Article  CAS  PubMed  Google Scholar 

  18. D. L. Damian, G. M. Halliday and R. S. Barnetson, Broad-spectrum sunscreens provide greater protection against ultraviolet-radiation-induced suppression of contact hypersensitivity to a recall antigen in humans, J. Invest. Dermatol., 1997, 109, 146–151.

    Article  CAS  PubMed  Google Scholar 

  19. T. S. Poon, R. S. Barnetson and G. M. Halliday, Prevention of immunosuppression by sunscreens in humans is unrelated to protection from erythema and dependent on protection from ultraviolet A in the face of constant ultraviolet B protection, J. Invest. Dermatol., 2003, 121, 184–190.

    Article  CAS  PubMed  Google Scholar 

  20. D. D. Moyal and A. M. Fourtanier, Broad-spectrum sunscreens provide better protection from solar ultraviolet-simulated radiation and natural sunlight-induced immunosuppression in human beings, J. Am. Acad. Dermatol., 2008, 58, S149–S154.

    Article  PubMed  Google Scholar 

  21. P. Autier, M. Boniol, G. Severi and J. F. Doré, European Organization for Research and Treatment of Cancer Melanoma Co-operative Group, Br. J. Dermatol., 2001, 144, 288–291.

    Article  CAS  PubMed  Google Scholar 

  22. F. Ismail, L. Mitchell, D. Casabonne, A. Gulati, R. Newton, C. M. Proby and C. A. Harwood, Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness, Br. J. Dermatol., 2006, 155, 916–925.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. C. A. Nowson and C. Margerison, Vitamin D intake and vitamin D status of Australians, Med. J. Aust., 2002, 177, 149–152.

    Article  PubMed  Google Scholar 

  24. A.-M. McCombie, R. S. Mason and D. L. Damian, Vitamin D deficiency in Sydney skin cancer patients, Med. J. Aust., 2009, 190, 102.

    Article  PubMed  Google Scholar 

  25. C. Munns, M. R. Zacharin, C. P. Rodda, J. A. Batch, R. Morely, N. E. Cranswick, M. E. Craig, W. S. Cutfeld, P. L. Hofman, B. J. Taylor, S. R. Grover, J. A. Pasco, D. Burgner and C. T. Cowel, Paediatric Endocrine Group and Paediatric Bone Australasia: Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement, Med. J. Aust., 2006, 185, 268–272.

    Article  PubMed  Google Scholar 

  26. M. F. Holick and T. C. Chen, Vitamin D deficiency: a worldwide problem with health consequences, Am. J. Clin. Nutr., 2008, 87, 1080S–1086S.

    Article  CAS  PubMed  Google Scholar 

  27. G. M. Halliday, Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis, Mutat. Res., Fundam. Mol. Mech. Mutagen., 2005, 571, 107–120.

    Article  CAS  Google Scholar 

  28. T. G. Rossman, A. N. Uddin, F. J. Burns and M. C. Bosland, Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis, Toxicol. Appl. Pharmacol., 2001, 176, 64–71.

    Article  CAS  PubMed  Google Scholar 

  29. D. Torchia, D. Massi, M. Caproni and P. Fabbri, Multiple cutaneous precanceroses and carcinomas from combined iatrogenic/professional exposure to arsenic, Int. J. Dermatol., 2008, 47, 592–593.

    Article  PubMed  Google Scholar 

  30. M. M. Rahman, U. K. Chowdhury, S. C. Mukherjee, B. K. Mondal, K. Paul, D. Lodh, B. K. Biswas, C. R. Chanda, G. K. Basu, K. C. Saha, S. Roy, R. Das, S. K. Palit, Q. Quamruzzaman and D. Chakraborti, Chronic arsenic toxicity in Bangladesh and West Bengal, India-a review and commentary, J. Toxicol. Clin. Toxicol., 2001, 39, 683–700.

    Article  CAS  PubMed  Google Scholar 

  31. H.-S. Yu, W.-T. JLiao, C.-Y. Chai, Arsenic carcinogenesis in the skin, J. Biomed. Sci., 2006, 13, 657–666.

    Article  CAS  PubMed  Google Scholar 

  32. A. Ludwig, M. Dietel, G. Schafer, K. Muller and H. Hilz, Nicotinamide and nicotinamide analogues as antitumour promoters in mouse skin, Cancer Res., 1990, 50, 2470–2475.

    CAS  PubMed  Google Scholar 

  33. H. L. Gensler, Prevention of photoimmunosuppression and photocarcinogenesis by topical nicotinamide, Nutr. Cancer, 1997, 29, 157–162.

    Article  CAS  PubMed  Google Scholar 

  34. E. Yiasemides, G. Sivapirabu, G. M. Halliday, J. Park and D. L. Damian, Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans, Carcinogenesis, 2009, 30, 101–105.

    Article  CAS  PubMed  Google Scholar 

  35. G. Sivapirabu, E. Yiasemides, G. M. Halliday, J. Park and D. L. Damian, Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans, Br. J. Dermatol., 2009, 161, 1357–1364.

    Article  CAS  PubMed  Google Scholar 

  36. H. L. Gensler, T. Williams, A. C. Huang and E. L. Jacobsen, Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice, Nutr. Cancer, 1999, 34, 36–41.

    Article  CAS  PubMed  Google Scholar 

  37. G. Magni, A. Amici, M. Emanuelli, G. Orsomando, N. Raffaelli and S. Ruggieri, Enzymology of NAD+ homeostasis in man, Cell. Mol. Life Sci., 2004, 61, 19–34.

    Article  CAS  PubMed  Google Scholar 

  38. M. C. Morris, D. A. Evans, J. L. Bienias, P. A. Scherr, C. C. Tangney, L. E. Hebert, D. A. Bennett, R. S. Wilson and N. Aggarwal, Dietary niacin and the risk of incident Alzheimer’s disease and of cognitive decline, J. Neurol., Neurosurg. Psychiatry, 2004, 75, 1093–1099.

    Article  CAS  Google Scholar 

  39. K. Karthikeyan and D. M. Thappa, Pellagra and skin, Int. J. Dermatol., 2002, 41, 476–481.

    Article  PubMed  Google Scholar 

  40. E. L. Jacobson, A. J. Dame, J. S. Pyrek and M. K. Jacobson, Evaluating the role of niacin in human carcinogenesis, Biochimie, 1995, 77, 394–398.

    Article  CAS  PubMed  Google Scholar 

  41. DrugDex(R) System, ed. R. Klasco, Thomsom Micromedex, Greenwood Village, Colorado, 2006.

    Google Scholar 

  42. J. Hegyi, R. A. Schwartz, V. Hegyi, Pellagra, dermatitis, dementia and diarrhea, Int. J. Dermatol., 2004, 43, 1–5.

    Article  PubMed  Google Scholar 

  43. G. M. Shah, R. G. Shah, H. Veillette, J. B. Kirkland, J. L. Pasieka and R. R. Warner, Biochemical assessment of niacin deficiency among carcinoid cancer patients, Am. J. Gastroenterol., 2005, 100, 2307–2314.

    Article  CAS  PubMed  Google Scholar 

  44. M. F. Murray, Tryptophan depletion and HIV infection: a metabolic link to pathogenesis, Lancet Infect. Dis., 2003, 3, 644–652.

    Article  CAS  PubMed  Google Scholar 

  45. D. Bilu, A. J. Mamelak, R. H. Nguyen, P. C. Queiroz, J. Kowalski, W. L. Morison and C. R. Martins, Clinical and epidemiologic characterization of photosensitivity in HIV-positive individuals, Photodermatol., Photoimmunol. Photomed., 2004, 20, 175–183.

    Article  Google Scholar 

  46. E. L. Jacobson, Niacin deficiency and cancer in women, J. Am. Coll. Nutr., 1993, 12, 412–416.

    Article  CAS  PubMed  Google Scholar 

  47. E. L. Jacobson, W. M. Shieh and A. C. Huang, Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis, Mol. Cell. Biol., 1999, 193, 69–74.

    CAS  Google Scholar 

  48. M. Knip, I. F. Douek, W. P. Moore, H. A. Gillmmor, A. E. McLean, P. J. Bingley and E. A. Gale, Safety of high-dose nicotinamide: a review, Diabetologia, 2000, 43, 1337–1345.

    Article  CAS  PubMed  Google Scholar 

  49. M. Kademian, M. Bechtel and M. Zirwas, Case reports: new onset flushing due to unauthorized substitution of niacin for nicotinamide, J. Drugs Dermatol., 2007, 6, 1220–1221.

    PubMed  Google Scholar 

  50. A. Petley, B. Macklin, A. G. Renwick and T. J. Wilkin, The pharmacokinetics of nicotinamide in humans and rodents, Diabetes, 1995, 44, 152–155.

    Article  CAS  PubMed  Google Scholar 

  51. Cosmetic Ingredient Review Expert Panel, Final report of the safety assessment of niacinamide and niacin, Int. J. Toxicol., 2005, 24, 1–31.

    Google Scholar 

  52. COLIPA, ed. R. Macmillan, The European Cosmetic Toiletry and Perfumery Association, Brussels, 1994, p. 21.

    Google Scholar 

  53. G. C. Chaidemenos, Tetracycline and niacinamide in the treatment of blistering skin diseases, Clin. Dermatol., 2001, 19, 781–785.

    Article  CAS  PubMed  Google Scholar 

  54. D. P. Fivenson, The mechanisms of action of nicotinamide and zinc in inflammatory skin disease, Cutis, 2006, 77, 5–10.

    PubMed  Google Scholar 

  55. R. W. Pero, B. Axelsson, D. Siemann, D. Chaplin and G. Dougherty, Newly discovered anti-inflammatory properties of the benzamides and nicotinamides, Mol. Cell. Biol., 1999, 193, 119–123.

    CAS  Google Scholar 

  56. N. M. Niren, Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review, Cutis, 2006, 11, 11–16.

    Google Scholar 

  57. T. Hakozaki, L. Minwalla, J. Zhuang, M. Chhoa, A. Matsubara, K. Miyamoto, A. Greatens, G. G. LHillebrand, D. L. Bissett and R. E. Boissy, The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer, Br. J. Dermatol., 2002, 147, 20–31.

    Article  CAS  PubMed  Google Scholar 

  58. O. Tanno, Y. Ota, N. Kitamura, T. Katsube and S. Inoue, Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier, Br. J. Dermatol., 2000, 143, 524–531.

    Article  CAS  PubMed  Google Scholar 

  59. X. Song, A. Xu, W. Pan, B. Wallin, R. Kivlin, S. Lu, C. Caio, Z. Bi and Y. Wan, Nicotinamide attenuates aquaporin 3 overexpression induced by retinoic acid through inhibition of EGFR/ERK in cultured human skin keratinocytes, Int. J. Mol. Med., 2008, 22, 229–236.

    CAS  PubMed  Google Scholar 

  60. D. L. Bissett, J. E. Oblong and C. A. Berge, Niacinamide: A B vitamin that improves aging facial skin appearance, Dermatol. Surg., 2005, 31, 860–865.

    Article  CAS  PubMed  Google Scholar 

  61. A. Kawada, N. Konishi, N. Oiso, S. Kawara and A. Date, Evaluation of anti-wrinkle effects of a novel cosmetic containing niacinamide, J. Dermatol., 2008, 35, 637–642.

    Article  CAS  PubMed  Google Scholar 

  62. E. L. Jacobson, P. U. Giacomoni, M. J. Roberts, G. T. Wondrak and M. K. Jacobson, Optimizing the energy status of skin cells during solar radiation, J. Photochem. Photobiol., B, 2001, 63, 141–147.

    Article  CAS  Google Scholar 

  63. C. M. Whitacre, H. Hashimoto, M.-L. Tsai, S. Chatterjee, S. J. Berger and N. A. Berger, Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences, Cancer Res., 1995, 55, 3697–3701.

    CAS  PubMed  Google Scholar 

  64. E. Riklis, R. Kor and R. Marko, Trends and developments in radioprotection: the effect of nicotinamide on DNA repair, Int. J. Radiat. Biol., 1990, 57, 699–708.

    Article  CAS  PubMed  Google Scholar 

  65. C. Cao, S. Lu, R. Kivlin, B. Wallin, E. Card, A. Bagdasarian, T. Tamakloe, W. J. Wang, X. Song, W. M. Chu, N. Kouttab, A. Xu and Y. Wan, SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes, J. Cell. Mol. Med., 2009, 13, 3632–3643.

    Article  PubMed  Google Scholar 

  66. N. A. Berger, Poly(ADP-ribose) in the cellular response to DNA damage, Radiat. Res., 1985, 101, 4–15.

    Article  CAS  PubMed  Google Scholar 

  67. J. M. de Murcia, C. Niedergang, C. Trucco, M. Ricoul, B. Dutrillax, M. Mark, F. J. Oliver, M. Masson, A. Dierich, M. LeMeur, C. Walztinger, P. Chambon, G. de Murcia, Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells, Proc. Natl. Acad. Sci. U. S. A., 1997, 94, 7303–7307.

    Article  PubMed  PubMed Central  Google Scholar 

  68. L. Virag and C. Szabo, The therapeutic potential of poly(ADP-ribose) polymerase inhibitors, Pharmacol. Rev., 2002, 54, 375–429.

    Article  CAS  PubMed  Google Scholar 

  69. M. L. Kripke, P. A. Cox, L. G. Alas and D. B. Yarosh, Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice, Proc. Natl. Acad. Sci. U. S. A., 1992, 89, 7516–7520.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. J. M. Kuchel, R. S. C. Barnetson and G. M. Halliday, Cyclobutane pyrimidine dimer formation is a molecular trigger for solar-simulated ultraviolet radiation-induced suppression of memory immunity in humans, Photochem. Photobiol. Sci., 2005, 4, 577–582.

    Article  CAS  PubMed  Google Scholar 

  71. W. Ying, P. Garnier and R. A. Swanson, NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes, Biochem. Biophys. Res. Commun., 2003, 308, 809–813.

    Article  CAS  PubMed  Google Scholar 

  72. A. C. Boyonoski, L. M. Gallacher, M. M. ApSimon, R. M. Jacobs, G. M. Shah, G. G. Poirier and J. B. Kirkland, Niacin deficiency increases the sensitivity of rats to the short and long term effects of ethylnitrosourea treatment, Mol. Cell. Biol., 1999, 193, 83–87.

    CAS  Google Scholar 

  73. D. L. Damian and G. M. Halliday, Measurement of ultraviolet radiation-induced suppression of recall contact and delayed-type hypersensitivity in humans, Methods, 2002, 28, 34–45.

    Article  CAS  PubMed  Google Scholar 

  74. T. A. Phan, G. M. Halliday, R. S. Barnetson and D. L. Damian, Spectral and dose dependence of ultraviolet radiation-induced immunosuppression, Front. Biosci., 2006, 11, 394–411.

    Article  CAS  PubMed  Google Scholar 

  75. D. L. Damian, R. S. Barnetson and G. M. Halliday, Low-dose UVA and UVB have different time courses for suppression of contact hypersensitivity to a recall antigen in humans, J. Invest. Dermatol., 1999, 112, 939–944.

    Article  CAS  PubMed  Google Scholar 

  76. P. Wolf, C. Hoffmenn, F. Quehenberger, S. Grinschgl and H. Kerl, Immune protection factors of chemical sunscreens measured in the local contact hypersensitivity model in humans, J. Invest. Dermatol., 2003, 121, 1080–1087.

    Article  CAS  PubMed  Google Scholar 

  77. D. L. Damian, R. S. Barnetson and G. M. Halliday, Effects of low-dose ultraviolet radiation on in vivo human cutaneous recall responses, Australas. J. Dermatol., 2001, 42, 161–167.

    Article  CAS  PubMed  Google Scholar 

  78. A. Friedmann, G. M. Halliday, R. S. Barnetson, V. E. Reeve, C. Walker, C. R. Patterson and D. L. Damian, The topical isoflavonoid NV-07α reduces solar-simulated UV-induced suppression of Mantoux reactions in humans, Photochem. Photobiol., 2004, 80, 416–421.

    Article  CAS  PubMed  Google Scholar 

  79. R. A. Howes, G. M. Halliday and D. L. Damian, Effect of topical melatonin on ultraviolet radiation-induced suppression of Mantoux reactions in humans, Photodermatol., Photoimmunol. Photomed., 2006, 22, 267–269.

    Article  CAS  Google Scholar 

  80. D. L. Damian, Y. J. Kim, K. M. Dixon, G. M. Halliday, A. Javeri and R. S. Mason, Topical calcitriol protects from UV-induced genetic damage but suppresses immunity in humans, Exp. Dermatol., 2009 10.1111/j.1600-0625.2009.00955.x.

    Google Scholar 

  81. R. A. Howes, G. M. Halliday, R. S. Barnetson, A. C. Friedmann and D. L. Damian, Topical capsaicin reduces ultraviolet radiation-induced suppression of Mantoux reactions in humans, J. Dermatol. Sci., 2006, 44, 113–115.

    Article  CAS  PubMed  Google Scholar 

  82. D. L. Damian, C. R. S. Patterson, M. Stapelberg, J. Park, R. S. Barnetson and G. M. Halliday, Ultraviolet radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide, J. Invest. Dermatol., 2008, 128, 447–454.

    Article  CAS  PubMed  Google Scholar 

  83. E. Yiasemides, G. Sivapirabu, G. M. Halliday, J. Park and D. L. Damian, Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans, Carcinogenesis, 2009, 30, 101–105.

    Article  CAS  PubMed  Google Scholar 

  84. D. Bouros, G. Zeros, C. Panaretos, C. Vassilatos and N. Siafakas, Palpation vs. pen method for the measurement of skin tuberculin reaction (Mantoux test), Chest, 1991, 99, 416–419.

    Article  CAS  PubMed  Google Scholar 

  85. K. Hiramoto, H. Tanaka, N. Yanagihara, E. F. Sato and M. Inoue, Effect of 17 beta-estradiol on immunosuppression induced by ultraviolet B irradiation, Arch. Dermatol. Res., 2004, 295, 307–311.

    Article  CAS  PubMed  Google Scholar 

  86. S. Widyarini, D. Domanski, N. Painter and V. E. Reeve, Estrogen receptor signaling protects against immune suppression by UV radiation exposure, Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 12837–12842.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. J. A. Foote, R. B. Harris, A. R. Giuliano, D. J. Roe, T. E. Moon, B. Cartmel and D. S. Alberts, Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults, Int. J. Cancer, 2001, 95, 7–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. R. Molife, P. Lorigan and S. MacNeil, Gender and survival in malignant melanoma, Cancer Treat. Rev., 2001, 27, 201–209.

    Article  CAS  PubMed  Google Scholar 

  89. J. S. Ungerstedt, M. Blomback and T. Soderstrom, Nicotinamide is a potent inhibitor of proinflammatory cytokines, Clin. Exp. Immunol., 2003, 131, 48–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. M. Hedman, J. Ludvigsson and M. K. Faresjo, Nicotinamide reduces high secretion of IFN-gamma in high-risk relatives even though it does not prevent type ! diabetes, J. Interferon Cytokine Res., 2006, 26, 207–213.

    Article  CAS  PubMed  Google Scholar 

  91. D. Decraene, K. Smaers, D. Maes, M. Matsui, L. Declercq and M. Garmyn, A low UVB dose, with the potential to trigger a protective p53-dependent gene program, increases the resilience of keratinocytes against future UVB insults, J. Invest. Dermatol., 2005, 125, 1026–1031.

    Article  CAS  PubMed  Google Scholar 

  92. F. J. Moloney, M. E. Vestergaard, B. L. Radojkovic and D. L. Damian, Randomised, double-blinded, placebo controlled study to assess the effect of topical 1% nicotinamide on actinic keratoses, Br. J. Dermatol., 2009, in press.

    Google Scholar 

  93. K. L. Bogan and C. Brenner, Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition, Annu. Rev. Nutr., 2008, 28, 115–130.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatology, Gloucester House Level 3, University of Sydney at Royal Prince Alfred Hospital Camperdown, NSW, 2050, Australia

    Diona L. Damian

Authors
  1. Diona L. Damian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Diona L. Damian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Damian, D.L. Photoprotective effects of nicotinamide. Photochem Photobiol Sci 9, 578–585 (2010). https://doi.org/10.1039/b9pp00146h

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1039/b9pp00146h

Search

Navigation